151 related articles for article (PubMed ID: 11940704)
1. Long-term survival after gene therapy for a recurrent glioblastoma.
Valéry CA; Seilhean D; Boyer O; Marro B; Hauw JJ; Kemeny JL; Marsault C; Philippon J; Klatzmann D
Neurology; 2002 Apr; 58(7):1109-12. PubMed ID: 11940704
[TBL] [Abstract][Full Text] [Related]
2. MRI characteristics and histological changes in glioblastoma after gene therapy.
Weber FW; Floeth FW; Reifenberger G; Felsberg J; Aulich A; Kiwit JC; Bock WJ
Front Radiat Ther Oncol; 1999; 33():244-52. PubMed ID: 10549494
[No Abstract] [Full Text] [Related]
3. Delayed response and survival from NovoTTF-100A in recurrent GBM.
Villano JL; Williams LE; Watson KS; Ignatius N; Wilson MT; Valyi-Nagy T; Michals EA; Engelhard HH
Med Oncol; 2013 Mar; 30(1):338. PubMed ID: 23307238
[TBL] [Abstract][Full Text] [Related]
4. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
5. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
Lee J; Ahn SS; Chang JH; Suh CO
Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
[TBL] [Abstract][Full Text] [Related]
7. ²³Na-MRI of recurrent glioblastoma multiforme after intraoperative radiotherapy: technical note.
Haneder S; Giordano FA; Konstandin S; Brehmer S; Buesing KA; Schmiedek P; Schad LR; Wenz F; Schoenberg SO; Ong MM
Neuroradiology; 2015 Mar; 57(3):321-6. PubMed ID: 25428586
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
[TBL] [Abstract][Full Text] [Related]
9. Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial.
Oraee-Yazdani S; Tavanaei R; Rostami F; Hajarizadeh A; Mehrabadi M; Akhlaghpasand M; Tamaddon M; Khannejad S; Yazdani KO; Zali A
J Transl Med; 2023 May; 21(1):350. PubMed ID: 37245011
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.
Hunn MK; Bauer E; Wood CE; Gasser O; Dzhelali M; Ancelet LR; Mester B; Sharples KJ; Findlay MP; Hamilton DA; Hermans IF
J Neurooncol; 2015 Jan; 121(2):319-29. PubMed ID: 25366363
[TBL] [Abstract][Full Text] [Related]
11. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent glioblastoma: state-of-the-art and future perspectives.
Di Nunno V; Franceschi E; Tosoni A; Di Battista M; Gatto L; Lamperini C; Minichillo S; Mura A; Bartolini S; Brandes AA
Expert Rev Anticancer Ther; 2020 Sep; 20(9):785-795. PubMed ID: 32799576
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
14. Recurrent glioblastoma: who receives tumor specific treatment and how often?
Steffens R; Semrau S; Lahmer G; Putz F; Lettmaier S; Eyüpoglu I; Buchfelder M; Fietkau R
J Neurooncol; 2016 May; 128(1):85-92. PubMed ID: 26907492
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
[TBL] [Abstract][Full Text] [Related]
16. Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.
Kanner AA; Wong ET; Villano JL; Ram Z;
Semin Oncol; 2014 Oct; 41 Suppl 6():S25-34. PubMed ID: 25213871
[TBL] [Abstract][Full Text] [Related]
17. Complete regression of anaplastic astrocytoma by intravenous tumor necrosis factor-alpha (TNF alpha) after recurrence: a case report.
Maruno M; Yoshimine T; Nakata H; Nishioka K; Kato A; Hayakawa T
Surg Neurol; 1994 Jun; 41(6):482-5. PubMed ID: 8059327
[TBL] [Abstract][Full Text] [Related]
18. [Current status and prospect in the treatment of glioblastoma].
Jiang HH; Lin S
Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):70-74. PubMed ID: 31902174
[TBL] [Abstract][Full Text] [Related]
19. Treating recurrent glioblastoma: an update.
Kamiya-Matsuoka C; Gilbert MR
CNS Oncol; 2015; 4(2):91-104. PubMed ID: 25768333
[TBL] [Abstract][Full Text] [Related]
20. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
